Lupin to market LG Life's glargine in India

 
• By Anju Ghangurde

More competition is set to arrive on the Indian insulin analog market. South Korea's LG Life Sciences is introducing its insulin glargine through Lupin on the Indian market.

More from Alimentary/Metabolic

More from Therapy Areas